Cedilla Therapeutics to Present at Upcoming Investor Conferences

On February 4, 2022 Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, reported that Alexandra Glucksmann, Ph.D., President and Chief Executive Officer will present a corporate update at the following upcoming investor conferences in February (Press release, Cedilla Therapeutics, FEB 4, 2022, View Source [SID1234607742]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

4th Annual Guggenheim Oncology Conference. Company presentation on Friday, February 11, at 11:00 a.m. ET.
BMO Biopharma Spotlight Series: Proteins – Degraders and Other Next Gen Technologies. Company presentation on Thursday, February 24, at 10:55 a.m. ET.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!